Why Inflammatory Signaling Holds the Key to Durable MDS Therapies - Dr Manja Wobus, Dr Katja Sockel
About this episode
This episode explores the potential of tasquinimod in restoring blood cell production and modifying the bone marrow microenvironment in MDS.
In this episode, host Dr Charles de Bock delves into groundbreaking preclinical research exploring the potential of tasquinimod to restore blood cell production and modify the bone marrow microenvironment in MDS with Dr Manja Wobus and Dr Katja Sockel. Join us as we unpack the mechanisms, animal studies, and future clinical prospects for this promising therapy. Read the accompanying article published in HemaSphere https://bit.ly/3OjuuiS i4MDS, EHA's Specialized Working Group information https://hsphere.pub/5d4
More episodes of HemaSphere Podcast
Explore listener stats, chart rankings, contacts and more on the HemaSphere Podcast podcast page.